Massachusetts' Exosome Diagnostics Snags $30 Million Post author:Sam Post published:July 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Johnson & Johnson's Potential Depression Blockbuster Esketamine Shows Promise in Phase II Study December 28, 2017 Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 Former Google Exec Steps Down as GRAIL CEO August 2, 2017
Johnson & Johnson's Potential Depression Blockbuster Esketamine Shows Promise in Phase II Study December 28, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017